Joel Morganroth
Director/Board Member at ACR Image Metrix
Joel Morganroth active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACR Image Metrix | Director/Board Member | 2011-10-26 | - |
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Director/Board Member | 2017-12-31 | - |
Career history of Joel Morganroth
Former positions of Joel Morganroth
| Companies | Position | Start | End |
|---|---|---|---|
| Perelman School of Medicine | Corporate Officer/Principal | - | - |
ERT Operating Co.
 ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA. | Director/Board Member | 1996-12-31 | - |
| Chief Executive Officer | 2010-12-31 | 2011-04-29 | |
| Chairman | 1998-12-31 | 2011-03-31 | |
| Chief Tech/Sci/R&D Officer | 2011-04-30 | - | |
| President | 2010-12-31 | 2011-04-29 |
Training of Joel Morganroth
| University of Michigan | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
ERT Operating Co.
ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA. | Commercial Services |
| ACR Image Metrix | |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Joel Morganroth
- Experience
